BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,152 filers reported holding BAXTER INTL INC in Q4 2021. The put-call ratio across all filers is 1.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $305,718 | -29.7% | 5,998 | -25.7% | 0.14% | -39.8% |
Q3 2022 | $435,000 | -16.2% | 8,078 | 0.0% | 0.24% | -12.3% |
Q2 2022 | $519,000 | -15.6% | 8,078 | +1.9% | 0.27% | -6.9% |
Q1 2022 | $615,000 | +2.5% | 7,925 | +13.5% | 0.29% | +5.5% |
Q4 2021 | $600,000 | +3.3% | 6,985 | -3.3% | 0.27% | -6.5% |
Q3 2021 | $581,000 | -1.2% | 7,220 | -1.2% | 0.29% | -1.0% |
Q2 2021 | $588,000 | -4.7% | 7,310 | 0.0% | 0.30% | -11.9% |
Q1 2021 | $617,000 | +3.7% | 7,310 | -1.3% | 0.34% | -0.3% |
Q4 2020 | $595,000 | -1.5% | 7,410 | -1.3% | 0.34% | -14.7% |
Q3 2020 | $604,000 | -6.6% | 7,510 | 0.0% | 0.40% | -9.6% |
Q2 2020 | $647,000 | +0.8% | 7,510 | -5.1% | 0.44% | -12.8% |
Q1 2020 | $642,000 | -3.5% | 7,910 | -0.5% | 0.50% | +23.4% |
Q4 2019 | $665,000 | -6.2% | 7,950 | -1.9% | 0.41% | -10.6% |
Q3 2019 | $709,000 | +7.4% | 8,100 | +0.6% | 0.45% | -1.9% |
Q2 2019 | $660,000 | -0.3% | 8,055 | -1.1% | 0.46% | -3.3% |
Q1 2019 | $662,000 | +23.5% | 8,145 | 0.0% | 0.48% | +8.4% |
Q4 2018 | $536,000 | -14.5% | 8,145 | +0.2% | 0.44% | -0.2% |
Q3 2018 | $627,000 | +3.0% | 8,130 | -1.5% | 0.44% | -19.5% |
Q2 2018 | $609,000 | +53.8% | 8,250 | +35.4% | 0.55% | +54.5% |
Q1 2018 | $396,000 | +0.5% | 6,095 | 0.0% | 0.36% | +2.6% |
Q4 2017 | $394,000 | +1.3% | 6,095 | -1.6% | 0.35% | -4.9% |
Q3 2017 | $389,000 | +3.2% | 6,195 | -0.4% | 0.36% | -1.1% |
Q2 2017 | $377,000 | +17.1% | 6,220 | 0.0% | 0.37% | +19.8% |
Q1 2017 | $322,000 | +12.2% | 6,220 | -3.8% | 0.31% | +8.5% |
Q4 2016 | $287,000 | – | 6,465 | – | 0.28% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Point | 36,000,000 | $2,658,240,000 | 18.52% |
SECTOR GAMMA AS | 721,058 | $53,243,000 | 8.85% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,747,061 | $202,843,000 | 5.38% |
Veritas Asset Management LLP | 8,852,005 | $653,632,000 | 5.36% |
Knowledge Leaders Capital, LLC | 79,384 | $5,862,000 | 4.39% |
HealthCor Management, L.P. | 1,800,000 | $132,912,000 | 4.22% |
Progressive Investment Management Corp | 79,282 | $5,854,000 | 3.78% |
13D Management LLC | 200,318 | $14,791,000 | 3.77% |
ARGENT CAPITAL MANAGEMENT LLC | 1,288,236 | $95,123,000 | 3.42% |
Chiron Investment Management, LLC | 612,787 | $45,248,000 | 3.12% |